Jenish Christin: The Clot Buster That Buys Time in Critical Moments
Jenish Christin, Critical Care Nurse Specialist- CTICU of ABUAD Multi-System Hospital, shared a post on LinkedIn:
“Streptokinase: The Clot Buster That Buys Time in Critical Moments
When minutes matter… reperfusion saves myocardium.
What is Streptokinase?
A fibrinolytic (thrombolytic) agent derived from Streptococci that activates plasminogen – plasmin, leading to clot breakdown.
Clinical Scenario
A 58-year-old male presents with:
- Crushing chest pain
- ST-elevation on ECG
- No PCI facility available
Streptokinase becomes a lifesaving option
Mechanism of Action
Streptokinase forms a complex with plasminogen:
- Converts more plasminogen to plasmin
- Degrades fibrin clot
- Restores blood flow
Indications
- STEMI (when PCI unavailable)
- Massive Pulmonary Embolism
- Deep Vein Thrombosis (selected cases)
- Arterial thrombosis
Contraindications (HIGH-YIELD)
- Active internal bleeding
- Recent surgery/trauma
- Hemorrhagic stroke history
- Severe uncontrolled hypertension
Adverse Effects
- Bleeding (most serious)
- Hypersensitivity reactions (foreign protein!)
- Hypotension during infusion
Clinical Pearl
- Prior streptococcal infection or previous use = antibody formation
- Reduced efficacy + ↑ risk of allergic reactions
Why not always Streptokinase?
Because newer agents (e.g., Alteplase) are:
- More fibrin-specific
- Faster acting
- Less antigenic
But In resource-limited settings, Streptokinase still saves lives daily
Bottom Line
Streptokinase may be old…
But in the right setting, at the right time – It’s the difference between life and death
Master the basics.
Save the critical.”
Stay updated with Hemostasis Today.
-
May 26, 2026, 06:43Francisco Epelde: Cardiac Lymphatic System as an Active Regulator of Myocardial Homeostasis
-
May 26, 2026, 06:39Reza Shojaei: How Neurology is Reshaping the Plasma Market?
-
May 26, 2026, 05:4779th World Health Assembly Approves Global Equity Resolution – EHC
-
May 26, 2026, 03:02Spelile Mutupira: Process of Blood Clotting After Injury
-
May 26, 2026, 03:00Clinton Otwori: Which Blood Product Do Healthcare Workers Most Commonly Misunderstand in Practice?
-
May 26, 2026, 02:58Toriqul Islam: EDTA-Induced Pseudothrombocytopenia
-
May 26, 2026, 02:34James O’Donnell Secures 2 Million Euros for a New Programme on The Irish ABO and Coagulation Study – RCSI
-
May 26, 2026, 02:26Joseph R. Shaw: Join The Annual CanVECTOR National Thrombosis Seminar on Precision in DOAC Reversal
-
May 26, 2026, 01:42Mili Doshi: The Role of Oral Health Teams in Supporting Stroke Rehabilitation and Recovery